Cash Transfers for People Experiencing Homelessness

May 9, 2022 updated by: Jiaying Zhao, University of British Columbia
The primary goal of the study is to determine the impacts of a one-time unconditional cash transfer on the well-being of people experiencing homelessness.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The goal of this project is to examine the effect of cash-transfers for people experiencing homelessness in Metro Vancouver. In partnership with Foundations for Social Change, we will distribute a one-time unconditional cash transfer of $8,500 to each of the 200 participants, with 200 additional participants in a control group who will not receive the cash transfer. To evaluate the effect of the cash transfer, participants will complete surveys 1, 2, 3, 6, 9, and 12 months after the cash transfer, and we will track important life outcomes such as housing, employment, health, cognitive function, and well-being.

Study Type

Interventional

Enrollment (Anticipated)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Participants must be homeless at the time of recruitment.
  2. Participants must be between 18 and 65 years of age, inclusive.
  3. Participants must be a Canadian citizen or permanent resident in Canada

Exclusion Criteria:

The following participants will be excluded:

  1. Participants who report severe problematic substance use (score ≥ 6 on DAST).
  2. Participants who report severe problematic alcohol use (score ≥ 20 on AUDIT).
  3. Participants who report severe psychiatric symptoms (score above 2 on item 5 or above 4 on items 13 or 14 on CSI).
  4. Participants who report problematic gambling behavior (score ≥ 8 on PGSI).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Cash
Participants will receive a one-time unconditional cash transfer of $8,500 CAD.
Participants will receive a one-time unconditional cash transfer of $8,500.
NO_INTERVENTION: Control
Participants will not receive a cash transfer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stable housing
Time Frame: 1-3 months
Number of days spent in stable housing.
1-3 months
Homelessness
Time Frame: 1-3 months
Number of days spent homeless.
1-3 months
Savings
Time Frame: 1-3 months
Total value of financial assets.
1-3 months
Total Spending
Time Frame: 1-3 months
Amount of money spent on regular and one-time purchases.
1-3 months
Spending on Rent
Time Frame: 1-3 months
Amount of money spent on rent.
1-3 months
Spending on temptation goods
Time Frame: 1-3 months
Amount of money spent on temptation goods, such as drugs, alcohol, and cigarettes.
1-3 months
Cost of shelter use
Time Frame: 1-3 months
Estimated societal cost of shelter use based on number of days staying in shelter
1-3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 2, 2022

Primary Completion (ANTICIPATED)

December 1, 2023

Study Completion (ANTICIPATED)

December 1, 2023

Study Registration Dates

First Submitted

May 9, 2022

First Submitted That Met QC Criteria

May 9, 2022

First Posted (ACTUAL)

May 13, 2022

Study Record Updates

Last Update Posted (ACTUAL)

May 13, 2022

Last Update Submitted That Met QC Criteria

May 9, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • H21-02584

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We will share non-identifiable data privately with other researchers.

IPD Sharing Time Frame

The data will become available after data collection has ended and after the data have been cleaned.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Personal Satisfaction

Clinical Trials on Cash transfer

Subscribe